Comparative Pharmacology
Head-to-head clinical analysis: CARIPRAZINE HYDROCHLORIDE versus GEODON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CARIPRAZINE HYDROCHLORIDE versus GEODON.
CARIPRAZINE HYDROCHLORIDE vs GEODON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cariprazine is a partial agonist at dopamine D3 and D2 receptors, with higher affinity for D3 receptors, and a partial agonist at serotonin 5-HT1A receptors; it is an antagonist at 5-HT2A and 5-HT2B receptors.
Ziprasidone is an atypical antipsychotic with high affinity for dopamine D2 and serotonin 5-HT2A receptors; it also antagonizes 5-HT2C, 5-HT1D, alpha1-adrenergic, and histamine H1 receptors, and moderately inhibits serotonin and norepinephrine reuptake.
1.5 mg orally once daily, with a recommended titration starting at 1.5 mg on day 1, increased to 3 mg on day 2, then 4.5 mg on day 3, and 6 mg on day 4; target dose range: 1.5–6 mg once daily, with a maximum of 6 mg/day.
20 mg orally twice daily with food; may titrate to 40-80 mg orally twice daily; maximum 80 mg orally twice daily. For acute treatment, IM 10-20 mg as needed up to 40 mg/day.
None Documented
None Documented
Terminal elimination half-life: 2–5 days (48–120 hours) for cariprazine and its major active metabolites (desmethylcariprazine, didesmethylcariprazine). The long half-life supports once-daily dosing and allows for gradual dose titration.
Terminal elimination half-life is approximately 7 hours (range 5-10 hours) for oral ziprasidone; after intramuscular administration, half-life is about 2-5 hours. This short half-life may require twice-daily dosing for oral therapy.
Primarily hepatic metabolism via CYP3A4 and CYP2D6, with 60% excreted in feces (mostly as metabolites) and 30% in urine (mostly as metabolites). Less than 1% excreted unchanged.
Primarily hepatic metabolism via aldehyde oxidase and CYP3A4. Approximately 20% excreted renally as unchanged drug, with the remainder as metabolites (mostly fecal).
Category C
Category C
Atypical Antipsychotic
Atypical Antipsychotic